In a new study, researchers from University of Copenhagen present what could be a much-needed helping hand to fight COVID-19.
Testing operations by the Immensa Health Clinic, Wolverhampton, have been suspended following an investigation into reports of people receiving negative PCR test results after they have previously tested positive on a Lateral Flow Device (LFD).
Vaccine clinical trial participants are to be offered the option to get additional vaccine doses from next week.
A new study has revealed important insights into the natural human antiviral defences against SARS-CoV-2, the virus that causes COVID-19.
The University of Kent’s School of Biosciences and the Institute of Medical Virology at Goethe-University, Frankfurt am Main, have identified a protein that may critically contribute to severe forms of COVID-19.
Millions of vulnerable people are to be offered a COVID-19 booster vaccine from next week as the Government confirmed it has accepted the final advice from the independent Joint Committee on Vaccination and Immunisation (JCVI).
An antibody treatment trialled at UCLH cuts the risk of developing symptomatic COVID-19 by 77%, according to results announced by AstraZeneca who developed the antibody known as AZD7442.
A new clinical trial will investigate whether a third dose of vaccine for people with weakened immune systems gives a stronger immune response than two doses.
Thousands of adults a day will be given free access to antibody tests through a new national surveillance programme launched by the UK Health Security Agency.
The Medicines and Healthcare products Regulatory Agency (MHRA) has given approval for the first monoclonal antibody treatment for the prevention and treatment of COVID-19 in the UK.
A new study is highlighting a need for widespread use of better face masks and the importance of good ventilation to mitigate the spread of COVID-19 indoors.
All young people aged 16 to 17 in England are to be offered a first dose of a COVID-19 vaccine by Monday 23 August to give them the vital protection provided by the vaccine before returning to school in September.
A national study involving UCLH has deepened understanding of the symptoms, signs and outcomes of patients with the novel condition vaccine-induced immune thrombocytopenia and thrombosis (VITT), associated with the Oxford/AstraZeneca vaccine.
More than one in ten COVID-19 patients in 314 UK hospitals caught the infection in hospital during the first pandemic wave, according to researchers conducting the world’s largest study of severe COVID-19.
Almost a third of cancer patients have reported receiving worse care since COVID-19 began, according to a new survey commissioned by Cancer Research UK.
Three quarters of adults in the UK have now received both doses of a COVID-19 vaccine, as the public continues to do what it can to protect themselves, their loved ones and their community.
The new NHS chief executive has urged young people to get the COVID jab as figures reveal that those aged 18-34 now make up more than one in five of those admitted to hospital with the virus.
England’s top midwife is urging expectant mums to get the COVID-19 vaccine after new data shows the overwhelming majority of pregnant women hospitalised with the virus have not had a jab.
NICE has published a new rapid COVID-19 guideline to help healthcare staff identify and treat patients who develop the rare syndrome vaccine-induced immune thrombocytopenia and thrombosis (VITT) after receiving COVID-19 vaccinations.